Inicio › Anemia aplásica › Maryland
Ensayos clínicos de Anemia aplásica en Maryland
10 estudios sobre Anemia aplásica buscan participantes en Maryland.
Ciudades en Maryland
Texto oficial del estudio (inglés)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2
Edades de 12 a 120 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06303193Cancer in Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
- National Cancer Institute - Shady Grove, Rockville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
1 Day – 100 Years · Todos los sexos · Actualizado el 12 nov 2026 · NCT00027274Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 4 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT01174108Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 2 a 99 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05012111Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 4 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT03520647Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
ReclutandoFase 1 temprana
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06398457Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2
Edades de 4 a 75 · Todos los sexos · Actualizado el 1 oct 2026 · NCT03173937A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 3 a 99 · Todos los sexos · Actualizado el 9 mar 2026 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Johns Hopkins University, Baltimore
ReclutandoFase 2
Edades de 3 a 75 · Todos los sexos · Actualizado el 17 feb 2026 · NCT06517641De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.